Nwam LLC Has $3.83 Million Stake in Danaher Corporation $DHR

Nwam LLC grew its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 28.2% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 20,089 shares of the conglomerate’s stock after purchasing an additional 4,414 shares during the period. Nwam LLC’s holdings in Danaher were worth $3,827,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Meeder Asset Management Inc. purchased a new position in shares of Danaher during the second quarter valued at approximately $44,000. MidFirst Bank purchased a new stake in Danaher in the 2nd quarter valued at $46,000. Bell Investment Advisors Inc bought a new position in Danaher during the 2nd quarter valued at $47,000. Fiduciary Financial Advisors purchased a new position in Danaher during the 2nd quarter worth $53,000. Finally, Solstein Capital LLC bought a new stake in shares of Danaher in the 2nd quarter worth $58,000. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently weighed in on DHR shares. Citigroup began coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. Piper Sandler began coverage on shares of Danaher in a research report on Thursday, June 11th. They issued a “neutral” rating and a $200.00 price objective for the company. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Royal Bank Of Canada lifted their target price on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Check Out Our Latest Stock Report on Danaher

Danaher Price Performance

Danaher stock opened at $213.90 on Tuesday. The business’s 50 day simple moving average is $200.18 and its 200 day simple moving average is $192.31. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The company has a market cap of $150.37 billion, a price-to-earnings ratio of 37.99, a PEG ratio of 2.69 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHRGet Free Report) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The business’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period last year, the business posted $0.77 earnings per share. Sell-side analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.